We're so glad you're here! This site is to help anyone diagnosed with Medullary Thyroid Cancer and their caregivers find valuable information and support. If you'd like to connect with others with MTC, please consider joining our very active Facebook Group. You don't have to go through this alone!
If you don't yet have a copy, please download the American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma, aka "The Guidelines." This is the MTC Bible. Read it and know it and it will help you and your doctor ensure you get the proper treatment.
Lastly, please consider looking into being seen by an MTC expert. We do our best to keep a running list of what we call "Centers of Excellence." These are doctors and facilities that are properly trained and experienced enough to treat MTC patients. It's one of the most important decisions you can make on your journey.
"The FDA has granted traditional approval to selpercatinib (Retevmo) for adult and pediatric patients 2 years and older with locally advanced or ..."
"The U.S. Food and Drug Administration fully approved selpercatinib (Retevmo) for adults and children aged at least 2 years with locally advanced ..."
"The FDA granted traditional approval to selpercatinib (Retevmo; Eli Lilly and Company) for the treatment of adult and pediatric patients aged 2 ..."
"In direct comparison, between F18 Dopa and 68Ga-FAPI for Medullary thyroid carcinoma- 68Ga-FAPI detected a higher number of metastases with higher ..."
"The Food and Drug Administration (FDA) has converted the accelerated approval of selpercatinib (Retevmo) to a traditional approval for adult and ..."
This website is intended for educational purposes only. It is not intended, nor should it be interpreted, as medical advice or instructions of any kind. Readers are advised to consult their own medical doctor(s) for all matters involving their health and medical care.